Anti-Toxoplasma In Vitro and In Vivo Activity of Pyrus boissieriana Arbutin-Rich Fraction
Authors:
- 17 January 2024
- journal article
- research article
- Published by Springer Nature in Acta Parasitologica
- Vol. 69 (1) , 567-573
Abstract
Purpose Pyrus boissieriana is a rich source of arbutin and has been used in herbal medicine to treat infectious diseases. This study aimed to investigate the effect of the arbutin-rich fraction of Pyrus boissieriana aerial parts on Toxoplasma gondii In Vitro and In Vivo. Methods An arbutin-rich fraction of P. boissieriana was prepared beforehand. Flow cytometry was used to evaluate the effect of different concentrations (1–512 µg/ml) of the P. boissieriana arbutin-rich fraction on Toxoplasma tachyzoites (RH strain). The cytotoxicity of the concentrations on the macrophage J774 cell line was also investigated by MTT assay. For In Vivo investigation, 4–6-week-old female mice infected with the RH strain of T. gondii were treated with different doses (16, 32, 64, 256, and 512 mg/kg) of the fraction using gavage. Results The highest and lowest lethality of the tachyzoites were 89.6% and 25.9% related to the concentrations of 512 µg/ml and 1 µg/ml, respectively, with an IC50 value of 18.1 µg/ml ± 0.37. The cytotoxicity test showed an IC50 value of 984.3 µg/ml ± 0.76 after 48 h incubation. The mean survival of mice at the lowest treated dose (16 mg/kg) was 6.6 days, and it was 15 days at the highest dose (512 mg/kg). The concentrations of 512, 256, 128, and 64 mg/kg of the fraction compared to the negative control (6.2 days mean survival) significantly increased the survival time of mice (P < 0.001, P = 0.009, P = 0.018, and P = 0.021, respectively). Conclusion The results showed that the arbutin-rich fraction of P. boissieriana is effective against T. gondii In Vitro and In Vivo and may be a reliable alternative to conventional treatment for toxoplasmosis, although further studies are necessary.Keywords
Funding Information
- Vice-Chancellor for Research, Shiraz University of Medical Sciences (21764)
This publication has 20 references indexed in Scilit:
- Treatment of Toxoplasmosis: Historical Perspective, Animal Models, and Current Clinical PracticeClinical Microbiology Reviews, 2018
- The significance of arbutin and its derivatives in therapy and cosmeticsPhytochemistry Letters, 2015
- Chronic bacterial prostatitis: efficacy of short-lasting antibiotic therapy with prulifloxacin (Unidrox®) in association with saw palmetto extract, lactobacillus sporogens and arbutin (Lactorepens®)BMC Urology, 2014
- HPTLC densitometric analysis of arbutin in bulk drug and methanolic extracts ofArctostaphylos uva-ursiNatural Product Research, 2011
- The History ofToxoplasma gondii—The First 100 YearsJournal of Eukaryotic Microbiology, 2008
- Antimicrobial Activities of Fruits ofCrataegus. andPyrus. SpeciesPharmaceutical Biology, 2006
- Benzoquinone, the substance essential for antibacterial activity in aqueous extracts from succulent young shoots of the pear Pyrus spp.Phytochemistry, 2003
- Photostability determination of arbutin, a vegetable whitening agentIl Farmaco, 2000
- Aloesin and arbutin inhibit tyrosinase activity in a synergistic manner via a different action mechanismArchives of Pharmacal Research, 1999
- New Benzyl Alcohol Glycosides fromPyrus bourgaeanaPlanta Medica, 1994